74 related articles for article (PubMed ID: 18006815)
1. Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state.
Yamamichi N; Inada K; Ichinose M; Yamamichi-Nishina M; Mizutani T; Watanabe H; Shiogama K; Fujishiro M; Okazaki T; Yahagi N; Haraguchi T; Fujita S; Tsutsumi Y; Omata M; Iba H
Cancer Res; 2007 Nov; 67(22):10727-35. PubMed ID: 18006815
[TBL] [Abstract][Full Text] [Related]
2. Discovery of BRM Targeted Therapies: Novel Reactivation of an Anti-cancer Gene.
Gramling S; Reisman D
Lett Drug Des Discov; 2011 Jan; 8(1):93-99. PubMed ID: 23565070
[TBL] [Abstract][Full Text] [Related]
3. BRM Targeting Compounds for the Potential Treatment of Cancer.
Kargbo RB
ACS Med Chem Lett; 2020 Feb; 11(2):99-100. PubMed ID: 32071673
[No Abstract] [Full Text] [Related]
4. Regulation of PTEN expression by the SWI/SNF chromatin-remodelling protein BRG1 in human colorectal carcinoma cells.
Watanabe T; Semba S; Yokozaki H
Br J Cancer; 2011 Jan; 104(1):146-54. PubMed ID: 21102582
[TBL] [Abstract][Full Text] [Related]
5. Marked intestinal trans-differentiation by autoimmune gastritis along with ectopic pancreatic and pulmonary trans-differentiation.
Takeuchi C; Sato J; Yamamichi N; Kageyama-Yahara N; Sasaki A; Akahane T; Aoki R; Nakajima S; Ito M; Yamamichi M; Liu YY; Sakuma N; Takahashi Y; Sakaguchi Y; Tsuji Y; Sakurai K; Tomida S; Niimi K; Ushijima T; Fujishiro M
J Gastroenterol; 2024 Feb; 59(2):95-108. PubMed ID: 37962678
[TBL] [Abstract][Full Text] [Related]
6. HELLS serves as a poor prognostic biomarker and its downregulation reserves the malignant phenotype in pancreatic cancer.
Wang FJ; Jing YH; Cheng CS; Cao ZQ; Jiao JY; Chen Z
BMC Med Genomics; 2021 Jul; 14(1):189. PubMed ID: 34315468
[TBL] [Abstract][Full Text] [Related]
7. The clinicopathological significance of SWI/SNF alterations in gastric cancer is associated with the molecular subtypes.
Huang SC; Ng KF; Chang IY; Chang CJ; Chao YC; Chang SC; Chen MC; Yeh TS; Chen TC
PLoS One; 2021; 16(1):e0245356. PubMed ID: 33481850
[TBL] [Abstract][Full Text] [Related]
8. Solid-type poorly differentiated adenocarcinoma of the stomach: Deficiency of mismatch repair and SWI/SNF complex.
Tsuruta S; Kohashi K; Yamada Y; Fujiwara M; Koga Y; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
Cancer Sci; 2020 Mar; 111(3):1008-1019. PubMed ID: 31922331
[TBL] [Abstract][Full Text] [Related]
9. BRM: the core ATPase subunit of SWI/SNF chromatin-remodelling complex-a tumour suppressor or tumour-promoting factor?
Jancewicz I; Siedlecki JA; Sarnowski TJ; Sarnowska E
Epigenetics Chromatin; 2019 Nov; 12(1):68. PubMed ID: 31722744
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of
Fang R; Xia Q; Sun J; Ng HZ; Liang Y; Wang X; Wang X; Ma H; Zhou X; Cheng Y; Rao Q
J Cancer; 2019; 10(21):5256-5263. PubMed ID: 31602276
[TBL] [Abstract][Full Text] [Related]
11. Large tumor size is a poor prognostic factor of gastric cancer with signet ring cell: Results from the surveillance, epidemiology, and end results database.
Zhou L; Li W; Cai S; Yang C; Liu Y; Lin Z
Medicine (Baltimore); 2019 Oct; 98(40):e17367. PubMed ID: 31577736
[TBL] [Abstract][Full Text] [Related]
12. Transduced caudal-type homeobox (CDX) 2/CDX1 can induce growth inhibition on CDX-deficient gastric cancer by rapid intestinal differentiation.
Nakayama C; Yamamichi N; Tomida S; Takahashi Y; Kageyama-Yahara N; Sakurai K; Takeuchi C; Inada KI; Shiogama K; Nagae G; Ono S; Tsuji Y; Niimi K; Fujishiro M; Aburatani H; Tsutsumi Y; Koike K
Cancer Sci; 2018 Dec; 109(12):3853-3864. PubMed ID: 30289576
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer.
Shu Y; Zhang W; Hou Q; Zhao L; Zhang S; Zhou J; Song X; Zhang Y; Jiang D; Chen X; Wang P; Xia X; Liao F; Yin D; Chen X; Zhou X; Zhang D; Yin S; Yang K; Liu J; Fu L; Zhang L; Wang Y; Zhang J; An Y; Cheng H; Zheng B; Sun H; Zhao Y; Wang Y; Xie D; Ouyang L; Wang P; Zhang W; Qiu M; Fu X; Dai L; He G; Yang H; Cheng W; Yang L; Liu B; Li W; Dong B; Zhou Z; Wei Y; Peng Y; Xu H; Hu J
Nat Commun; 2018 Jun; 9(1):2447. PubMed ID: 29961079
[TBL] [Abstract][Full Text] [Related]
14. Expression of Gastric Markers Is Associated with Malignant Potential of Nonampullary Duodenal Adenocarcinoma.
Minatsuki C; Yamamichi N; Inada KI; Takahashi Y; Sakurai K; Shimamoto T; Tsuji Y; Shiogama K; Kodashima S; Sakaguchi Y; Niimi K; Ono S; Niwa T; Ohata K; Matsuhashi N; Ichinose M; Fujishiro M; Tsutsumi Y; Koike K
Dig Dis Sci; 2018 Oct; 63(10):2617-2625. PubMed ID: 29956011
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers.
Puneet ; Kazmi HR; Kumari S; Tiwari S; Khanna A; Narayan G
Pathol Oncol Res; 2018 Oct; 24(4):757-770. PubMed ID: 29552712
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic submucosal dissection for papillary adenocarcinoma of the stomach: is it really safe?
Lee HJ; Kim GH; Park DY; Kim YK; Jeon HK; Lee BE; Song GA
Gastric Cancer; 2017 Nov; 20(6):978-986. PubMed ID: 28271420
[TBL] [Abstract][Full Text] [Related]
17. BRM Promoter Polymorphisms and Survival of Advanced Non-Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 Trial.
Liu G; Cuffe S; Liang S; Azad AK; Cheng L; Brhane Y; Qiu X; Cescon DW; Bruce J; Chen Z; Cheng D; Patel D; Tse BC; Laurie SA; Goss G; Leighl NB; Hung R; Bradbury PA; Seymour L; Shepherd FA; Tsao MS; Chen BE; Xu W; Reisman DN
Clin Cancer Res; 2017 May; 23(10):2460-2470. PubMed ID: 27827316
[No Abstract] [Full Text] [Related]
18. Epigenomic regulation of oncogenesis by chromatin remodeling.
Kumar R; Li DQ; Müller S; Knapp S
Oncogene; 2016 Aug; 35(34):4423-36. PubMed ID: 26804164
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological Characteristics and Survival Outcomes of Primary Signet Ring Cell Carcinoma in the Stomach: Retrospective Analysis of Single Center Database.
Liu X; Cai H; Sheng W; Yu L; Long Z; Shi Y; Wang Y
PLoS One; 2015; 10(12):e0144420. PubMed ID: 26642199
[TBL] [Abstract][Full Text] [Related]
20. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.
Karnezis AN; Wang Y; Ramos P; Hendricks WP; Oliva E; D'Angelo E; Prat J; Nucci MR; Nielsen TO; Chow C; Leung S; Kommoss F; Kommoss S; Silva A; Ronnett BM; Rabban JT; Bowtell DD; Weissman BE; Trent JM; Gilks CB; Huntsman DG
J Pathol; 2016 Feb; 238(3):389-400. PubMed ID: 26356327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
